EyePoint Pharmaceuticals
EYPT
$19.74
Share price
-1.00%
Change (1 day)
191.15%
Change (1 year)
Categories
EPS for EyePoint Pharmaceuticals (EYPT)
EPS in 2023 (TTM): -$2.66
According to EyePoint Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is -$2.66. In 2022 the company made an earnings per share (EPS) of -$2.73 a decrease over its 2021 EPS that were of -$2.02.
EPS history for EyePoint Pharmaceuticals from 2003 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | -$2.66 | -2.56% |
| 2022 | -$2.73 | 35.15% |
| 2021 | -$2.02 | -43.1% |
| 2020 | -$3.55 | -36.61% |
| 2019 | -$5.60 | -57.89% |
| 2018 | -$13.30 | 125.42% |
| 2017 | -$5.90 | 6.89% |
| 2016 | -$5.52 | -20.01% |
| 2015 | -$6.90 | -302.94% |
| 2014 | $3.40 | -160.71% |
| 2013 | -$5.60 | 21.74% |
| 2012 | -$4.60 | -58.18% |
| 2011 | -$11.00 | -540% |
| 2010 | $2.50 | -266.67% |
| 2009 | -$1.50 | -95.83% |
| 2008 | -$36.01 | 263.55% |
| 2007 | -$9.91 | -97.6% |
| 2006 | -$413.54 | 3202.71% |
| 2005 | -$12.52 | 3485.24% |
| 2004 | -$0.35 | 87.91% |
| 2003 | -$0.19 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 Nymox Pharmaceutical NYMX | -$0.06000 | -97.74% | Bahamas |
 NRC Health
NRC | $1.19 | -144.74% | 🇺🇸 USA |